Advantage Podcast Test Feed

CE in the Mornings Educational Series Faculty Interviews Summary: Interview with CE in the Morning Faculty. This interview was produced by ASHP Advantage and supported by an educational grant from Merck. It was recorded in December 2011 during the 46th ASHP Midyear Clinical Meeting and Exhibition in New Orleans. More information about this topic is available at www.cemornings.com. Susan Cornell, Pharm.D., CDE, FAPhA, FAADE Assistant Director of Experiential Education and Associate Professor of Pharmacy Practice Midwestern University Chicago College of Pharmacy Downers Grove, Illinois C.E. Credits: This activity is not eligible for continue education credits.

CE in the Mornings Educational Series Faculty Interviews Summary: Interview with CE in the Morning Faculty. This interview was produced by ASHP Advantage and supported by an educational grant from Merck. It was recorded in December 2011 during the 46th ASHP Midyear Clinical Meeting and Exhibition in New Orleans. More information about this topic is available at www.cemornings.com. Dennis M. Williams, Pharm.D., BCPS Associate Professor and Vice Chair Department of Pharmacotherapy and Experimental Therapeutics UNC Eshelman School of Pharmacy University of North Carolina Chapel Hill, North Carolina C.E. Credits: This activity is not eligible for continue education credits.

CE in the Mornings Educational Series Faculty Interviews Summary: Interview with CE in the Morning Faculty. This interview was produced by ASHP Advantage and supported by an educational grant from Merck. It was recorded in December 2011 during the 46th ASHP Midyear Clinical Meeting and Exhibition in New Orleans. More information about this topic is available at www.cemornings.com. Joseph Saseen, Pharm.D., FASHP, FCCP, BCPS Professor, Clinical Pharmacy and Family Medicine Vice Chair, Department of Clinical Pharmacy University of Colorado Anschutz Medical Center Aurora, Colorado C.E. Credits: This activity is not eligible for continue education credits.

CE in the Mornings Educational Series Faculty Interviews Summary: Interview with CE in the Morning Faculty. This interview was produced by ASHP Advantage and supported by an educational grant from Merck. It was recorded in December 2011 during the 46th ASHP Midyear Clinical Meeting and Exhibition in New Orleans. More information about this topic is available at www.cemornings.com. Craig Martin, Pharm.D., BCPS-ID Pharmacist, Specialist-Infectious Diseases Associate Professor of Pharmacy and Medicine UK HealthCare, University of Kentucky College of Pharmacy Lexington, Kentucky C.E. Credits: This activity is not eligible for continue education credits.

Stroke Prevention in Atrial Fibrillation: Faculty Interviews (1 of 3) Summary: Interview regarding the Stroke Prevention in Atrial Fibrillation: Updated Guidelines and Expanding Treatment Options. This interview was produced by ASHP Advantage and supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. It was recorded in December 2011 during the 46th ASHP Midyear Clinical Meeting and Exhibition in New Orleans. More information about this topic is available at www.ashpadvantage.com/preventstroke Cynthia A. Sanoski, Pharm.D., FCCP, BCPS, Activity Chair Chair and Associate Professor Department of Pharmacy Practice Jefferson School of Pharmacy Thomas Jefferson University Philadelphia, Pennsylvania C.E. Credits: This activity is not eligible for continue education credits.

Stroke Prevention in Atrial Fibrillation: Faculty Interviews (2 of 3) Summary: Interview regarding the Stroke Prevention in Atrial Fibrillation: Updated Guidelines and Expanding Treatment Options. This interview was produced by ASHP Advantage and supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. It was recorded in December 2011 during the 46th ASHP Midyear Clinical Meeting and Exhibition in New Orleans. More information about this topic is available at www.ashpadvantage.com/preventstroke James S. Kalus, Pharm.D., BCPS (AQ-Cardiology) Senior Manager, Patient Care Services Department of Pharmacy Services Henry Ford Hospital Detroit, Michigan C.E. Credits: This activity is not eligible for continue education credits.

Stroke Prevention in Atrial Fibrillation: Faculty Interviews (3 of 3) Summary: Interview regarding the Stroke Prevention in Atrial Fibrillation: Updated Guidelines and Expanding Treatment Options. This interview was produced by ASHP Advantage and supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. It was recorded in December 2011 during the 46th ASHP Midyear Clinical Meeting and Exhibition in New Orleans. More information about this topic is available at www.ashpadvantage.com/preventstroke Nancy L. Shapiro, Pharm.D., FCCP, BCPS Clinical Associate Professor Operations Manager, Antithrombosis Clinic The University of Illinois at Chicago College of Pharmacy and Medical Center Chicago, Illinois C.E. Credits: This activity is not eligible for continue education credits.

Roundtable Discussion Regarding the Management of Hyponatremia in Hospitalized Patients (Part 3 of 3) Summary: Mr. Joseph Dasta leads a roundtable discussion with fellow faculty members, Drs. Michael Cawley and Henry Cohen. This discussion was produced by ASHP Advantage and supported by an educational grant from Otsuka America Pharmaceutical, Inc. It was recorded in December 2011 during the 46th ASHP Midyear Clinical Meeting and Exhibition in New Orleans. More information about this topic is available at www.ashpadvantage.com/hyponatremia Faculty: Joseph F. Dasta, M.S., FCCM, FCCP, Activity Chair Professor Emeritus The Ohio State University College of Pharmacy Columbus, Ohio Adjunct Professor The University of Texas College of Pharmacy Austin, Texas Michael J. Cawley, Pharm.D., RRT, CPFT Associate Professor of Clinical Pharmacy Philadelphia College of Pharmacy University of the Sciences Philadelphia, Pennsylvania Henry Cohen, M.S., Pharm.D., BCPP, FCCM, CGP Professor of Pharmacy Practice Arnold & Marie Schwartz College of Pharmacy and Health Sciences Long Island University Chief Pharmacotherapy Officer Kingsbrook Jewish Medical Center Brooklyn, New York C.E. Credits: This activity is not eligible for continue education credits.

Roundtable Discussion Regarding the Management of Hyponatremia in Hospitalized Patients (Part 2 of 3) Summary: Mr. Joseph Dasta leads a roundtable discussion with fellow faculty members, Drs. Michael Cawley and Henry Cohen. This discussion was produced by ASHP Advantage and supported by an educational grant from Otsuka America Pharmaceutical, Inc. It was recorded in December 2011 during the 46th ASHP Midyear Clinical Meeting and Exhibition in New Orleans. More information about this topic is available at www.ashpadvantage.com/hyponatremia Faculty: Joseph F. Dasta, M.S., FCCM, FCCP, Activity Chair Professor Emeritus The Ohio State University College of Pharmacy Columbus, Ohio Adjunct Professor The University of Texas College of Pharmacy Austin, Texas Michael J. Cawley, Pharm.D., RRT, CPFT Associate Professor of Clinical Pharmacy Philadelphia College of Pharmacy University of the Sciences Philadelphia, Pennsylvania Henry Cohen, M.S., Pharm.D., BCPP, FCCM, CGP Professor of Pharmacy Practice Arnold & Marie Schwartz College of Pharmacy and Health Sciences Long Island University Chief Pharmacotherapy Officer Kingsbrook Jewish Medical Center Brooklyn, New York C.E. Credits: This activity is not eligible for continue education credits.

Roundtable Discussion Regarding the Management of Hyponatremia in Hospitalized Patients (Part 1 of 3) Summary: Mr. Joseph Dasta leads a roundtable discussion with fellow faculty members, Drs. Michael Cawley and Henry Cohen. This discussion was produced by ASHP Advantage and supported by an educational grant from Otsuka America Pharmaceutical, Inc. It was recorded in December 2011 during the 46th ASHP Midyear Clinical Meeting and Exhibition in New Orleans. More information about this topic is available at www.ashpadvantage.com/hyponatremia Faculty: Joseph F. Dasta, M.S., FCCM, FCCP, Activity Chair Professor Emeritus The Ohio State University College of Pharmacy Columbus, Ohio Adjunct Professor The University of Texas College of Pharmacy Austin, Texas Michael J. Cawley, Pharm.D., RRT, CPFT Associate Professor of Clinical Pharmacy Philadelphia College of Pharmacy University of the Sciences Philadelphia, Pennsylvania Henry Cohen, M.S., Pharm.D., BCPP, FCCM, CGP Professor of Pharmacy Practice Arnold & Marie Schwartz College of Pharmacy and Health Sciences Long Island University Chief Pharmacotherapy Officer Kingsbrook Jewish Medical Center Brooklyn, New York C.E. Credits: This activity is not eligible for continue education credits.

Optimizing Bone Health in Cancer Patients Summary: Improvements in cancer treatment have increased survival and the need for effective interventions to reduce the risk for skeletal-related events including pathologic bone fractures, spinal cord compression, need for surgery or radiation therapy to bone, and hypercalcemia of malignancy. Many cancer therapies cause bone loss, which increases the risk for fractures. Bisphosphonates are useful for treating bone metastases and slowing or preventing cancer treatment-induced bone loss (CTIBL). These drugs also may reduce the risk of recurrence and improve survival in patients with early breast cancer or other solid tumors. RANK-ligand Inhibitors have also been shown to decrease skeletal-related events in patients with bone metastases from solid tumors. Other agents for the treatment of bone metastases are under investigation. Knowledge of the role of bisphosphonates and new and emerging bone-targeted therapies in treating patients with bone metastases or CTIBL will enable pharmacists to take an active role in the management of these patients. Chad M. Barnett, Pharm.D., BCOP Co-Chair Clinical Pharmacy Specialist Breast Oncology Division of Pharmacy University of Texas M.D. Anderson Cancer Center Houston, Texas C.E. Credits: This activity was recorded on April 14, 2011. Continuing education credit for this podcast is available through May 23, 2012. To be eligible for continuing education credit, you must complete the post-test and post-activity evaluation online at the ASHP Advantage CE Testing Center.

Alternative Approaches to Oral Antiplatelet Management in Acute Coronary Syndrome Summary: The content for this podcast was adapted from an interview with Paul Dobesh recorded in December 2010 during the 45th ASHP Midyear Clinical Meeting and Exhibition. Dr. Dobesh is Associate Professor of Pharmacy Practice at the University of Nebraska Medical Center in Omaha. He also is chair of this educational initiative coordinated by ASHP Advantage. Paul P. Dobesh, Pharm.D., FCCP, BCPS (AQ Cardiology) Associate Professor of Pharmacy Practice College of Pharmacy University of Nebraska Medical Center Omaha, Nebraska C.E. Credits: Not available for this activity.

Potential Use of Platelet Function and Genetic Testing in Guiding Oral Antiplatelet Therapy in Acute Coronary Syndrome Summary: The content for this podcast was adapted from an interview with Julie Oestreich recorded in December 2010 during the 45th ASHP Midyear Clinical Meeting and Exhibition. Dr. Oestreich is Assistant Professor in the Department of Pharmacy Practice in the College of Pharmacy at the University of Nebraska Medical Center (UNMC) in Omaha. Dr. Oestreich discusses some of the clinical challenges in oral antiplatelet therapy, especially as they relate to platelet function and genetic testing. Julie H. Oestreich, Pharm.D., Ph.D. Assistant Professor of Pharmacy Practice College of Pharmacy University of Nebraska Medical Center Omaha, Nebraska C.E. Credits: Not available for this activity.

Current Options for Managing Antiplatelet Therapy in Patients with Acute Coronary Syndrome. Summary: The content for this podcast was adapted from an interview with Toby Trujillo recorded in December 2010 during the 45th ASHP Midyear Clinical Meeting and Exhibition. Dr. Trujillo is Associate Professor of Clinical Pharmacy at the University of Colorado Denver School of Pharmacy in Aurora, Colorado. He also serves as Clinical Specialist in cardiovascular pharmacotherapy and anticoagulation at University of Colorado Hospital. Dr. Trujillo discusses issues related to current options for managing antiplatelet therapy in patients with acute coronary syndrome. Toby C. Trujillo, Pharm.D., BCPS (AQ Cardiology) Associate Professor University of Colorado Denver School of Pharmacy Clinical Specialist – Cardiology/Anticoagulation University of Colorado Hospital Aurora, Colorado C.E. Credits: Not available for this activity.

Atrial Fibrillation: Focus on Stroke Prevention Summary: The content for this podcast was adapted from an interview with Ann Wittkowsky that was recorded on December 5th, 2010, during the 45th ASHP Midyear Clinical Meeting and Exhibition in Anaheim, California. Dr. Wittkowsky is Clinical Professor at the University of Washington School of Pharmacy, and Director of Anticoagulation Services at the University of Washington Medical Center in Seattle, Washington. Dr. Wittkowsky will discuss the Role of the Pharmacist in Identifying and Overcoming Barriers to Appropriate and Well-managed Antithrombotic Therapy. Ann K. Wittkowsky, Pharm.D., CACP, FASHP, FCCP Clinical Professor University of Washington School of Pharmacy Director, Anticoagulation Services University of Washington Medical Center Seattle, Washington C.E. Credits: Not available for this activity.

Atrial Fibrillation: Focus on Stroke Prevention Summary: The content for this podcast was adapted from an interview with James Kalus that was recorded on December 6th, 2010, during the 45th ASHP Midyear Clinical Meeting and Exhibition in Anaheim, California. Dr. Kalus is Senior Manager, Patient Care Services of the Department of Pharmacy Services at Henry Ford Hospital in Detroit, Michigan. Dr. Kalus will discuss Future Directions: Emerging Therapies for Stroke Prevention in Atrial Fibrillation. James S. Kalus, Pharm.D., BCPS (AQ-Cardiology) Senior Manager, Patient Care Services Department of Pharmacy Services Henry Ford Hospital Detroit, Michigan C.E. Credits: Not available for this activity.

Atrial Fibrillation: Focus on Stroke Prevention Summary: The content for this podcast was adapted from an interview with Cynthia Sanoski that was recorded on December 5th, 2010, during the 45th ASHP Midyear Clinical Meeting and Exhibition in Anaheim, California. Dr. Sanoski is Chair and Associate Professor of the Department of Pharmacy Practice at Jefferson School of Pharmacy, Thomas Jefferson University in Philadelphia, Pennsylvania. Dr. Sanoski will discuss Stroke Prevention in Atrial Fibrillation: Reviewing the Basics. Cynthia A. Sanoski, Pharm.D., FCCP, BCPS, Initiative Chair Chair and Associate Professor Department of Pharmacy Practice Jefferson School of Pharmacy Thomas Jefferson University Philadelphia, Pennsylvania C.E. Credits: Not available for this activity.

Clinical Considerations of Risk Evaluation and Mitigation Strategies in Health Care Systems: Design, Implementation, and Management Summary: The content for this podcast was adapted from an interview with JoAnn Stubbings recorded in December 2010 during the 45th ASHP Midyear Clinical Meeting and Exhibition. Ms. Stubbings is Manager of Research and Public Policy in the Ambulatory Care Pharmacy Department at the University of Illinois (UIC) at Chicago College of Pharmacy and Clinical Associate Professor in the Department of Pharmacy Practice. She also serves as chair of the risk evaluation and mitigation strategies educational initiative coordinated by ASHP Advantage. Ms. Stubbings will discuss practical applications and opportunities presented by REMS. JoAnn Stubbings, MHCA, B.S. Pharm. Clinical Associate Professor Manager, Research and Public Policy University of Illinois at Chicago College of Pharmacy Chicago, Illinois C.E. Credits: Not available for this activity.

The Background, History and Current Status of Risk Evaluation and Mitigation Strategies. Summary: The content for this podcast was adapted from an interview with Stephen Goldman recorded in December 2010 during the 45th ASHP Midyear Clinical Meeting and Exhibition. Dr. Goldman is an independent consultant with extensive experience in academic and clinical medicine, public health, federal medical product safety regulations, and the pharmaceutical industry. Stephen A. Goldman, M.D., FAPM, DFAPA Former Medical Director, MedWatch,U.S. Food and Drug Administration Managing Member, Stephen A. Goldman Consulting Services, LLC Morris Plains, New Jersey C.E. Credits: Not available for this activity.

A Look at the Future of Biosimilars and What Physicians and Pharmacists Should Anticipate with Their Arrival on the U.S. Market (Part 2 of 2) James H. Hoffman, Pharm.D. Medication Safety Officer St. Jude Children’s Hospital Memphis, Tennessee Ajay K. Singh, MBBS Associate Professor of Medicine at the Brigham and Women’s Hospital and Harvard Medical School Boston, Massachusetts The content for this podcast was adapted from a dialog that was recorded on August 23, 2010 in Boston, Massachusetts between James H. Hoffman and Ajay K. Singh. The dialog focuses on the various clinical and regulatory aspects concerning the eventual introduction of biosimilars in the United States. After considerable debate, recent legislation has provided a legal framework for the approval of biosimilars in the U.S. Although certain details of the regulatory process still need to be resolved and the first biosimilar may not be approved for another year or two, health care professionals will need to be educated about biosimilars in order to make sound policy and clinical decisions regarding their use. C.E. Credits: Not available for this activity. Additional Information: www.biosimcentral.org

A Look at the Future of Biosimilars and What Physicians and Pharmacists Should Anticipate with Their Arrival on the U.S. Market (Part 1 of 2) James H. Hoffman, Pharm.D. Medication Safety Officer St. Jude Children’s Hospital Memphis, Tennessee Ajay K. Singh, MBBS Associate Professor of Medicine at the Brigham and Women’s Hospital and Harvard Medical School Boston, Massachusetts The content for this podcast was adapted from a dialog that was recorded on August 23, 2010 in Boston, Massachusetts between James H. Hoffman and Ajay K. Singh. The dialog focuses on the various clinical and regulatory aspects concerning the eventual introduction of biosimilars in the United States. After considerable debate, recent legislation has provided a legal framework for the approval of biosimilars in the U.S. Although certain details of the regulatory process still need to be resolved and the first biosimilar may not be approved for another year or two, health care professionals will need to be educated about biosimilars in order to make sound policy and clinical decisions regarding their use. C.E. Credits: Not available for this activity. Additional Information: www.biosimcentral.org

During the week of March 2nd through the 8th in 2008, ASHP and the ASHP Research and Education Foundation marked National Patient Safety Awareness Week with a radio tour. The radio tour emphasized the pharmacists' role in medication safety. Dr. Scott T. Micek, a clinical pharmacist at Barnes-Jewish Hospital in St. Louis, was interviewed by 17 radio stations, including CNN Radio. The interviews were designed to educate consumers about the vital patient-care role pharmacists play in hospitals and health systems. This podcast includes the interview with WIBW in Topeka, Kansas. Permission to share this interview with the public was granted by the Kansas Information Network and James Doblin, who conducted the interview.) The Barnes-Jewish Hospital's team, which was led by Dr. Micek, received the 2007 Award for Excellence in Medication-Use Safety. The ASHP Foundation created the Award for Excellence in Medication-Use Safety in 2004. It is the only award program to honor a pharmacist-led, multidisciplinary team for its significant institution-wide system improvements relating to medication use. The $50,000 award recognizes on a national level pharmacy professionals who have assumed a leadership role in promoting safety in the medication-use process. The award is sponsored by the Cardinal Health Foundation. For more information, please visit www.ashpfoundation.org.

During the week of March 2nd through the 8th in 2008, ASHP and the ASHP Research and Education Foundation marked National Patient Safety Awareness Week with a radio tour. The radio tour emphasized the pharmacists' role in medication safety. Dr. Scott T. Micek, a clinical pharmacist at Barnes-Jewish Hospital in St. Louis, was interviewed by 17 radio stations, including CNN Radio. The interviews were designed to educate consumers about the vital patient-care role pharmacists play in hospitals and health systems. This podcast includes the interview with WIBW in Topeka, Kansas. Permission to share this interview with the public was granted by the Kansas Information Network and James Doblin, who conducted the interview.) The Barnes-Jewish Hospital's team, which was led by Dr. Micek, received the 2007 Award for Excellence in Medication-Use Safety. The ASHP Foundation created the Award for Excellence in Medication-Use Safety in 2004. It is the only award program to honor a pharmacist-led, multidisciplinary team for its significant institution-wide system improvements relating to medication use. The $50,000 award recognizes on a national level pharmacy professionals who have assumed a leadership role in promoting safety in the medication-use process. The award is sponsored by the Cardinal Health Foundation. For more information, please visit www.ashpfoundation.org.